Technology: CAR-T, CAR-T therapy
Industry: CAR-T, Public
Headquarters: New York, New York, United States
Founded Date: 2015-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 4
Total Funding: 204300000
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-03-08
Last Funding Type: Post-IPO Debt

Visit Website
info@mustangbio.com
Register and Claim Ownership